Skip to Content

Atlas Arteria Ltd

ALX: XASX (AUS)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
A$7.60ZpprsMdbvdqtm

Atlas Arteria: A Weak Start to the Year but Longer-Term View Is Intact

Narrow-moat Atlas Arteria’s first-quarter traffic results were relatively weak. Despite the benefit of an extra day in February, weighted average traffic growth was negative 0.7% compared with the previous corresponding period. Revenue growth was 2.9%. Revenue and traffic are tracking below our full-year forecasts, primarily due to one-offs like farmers’ strikes and severe snowstorms. We downgrade our 2024 expectations slightly, but longer-term forecasts are largely unchanged. We maintain our AUD 5.60 per security fair value estimate and consider the stock fairly valued.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of ALX so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center